Position in JNJ
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$100,773,812
+$13,187,606 QoQ
Shares Held
412,264
-2.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
1.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Allworth Financial LP holds $325,693,383 across 18 Drug Manufacturers - General names. JNJ ranks #1 (30.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
412,264 | $100,773,812 | |
| 2 | LLY |
ELI LILLY & Co
|
66,228 | $60,914,527 | |
| 3 | ABBV |
AbbVie Inc.
|
263,766 | $57,366,467 | |
| 4 | MRK |
Merck & Co., Inc.
|
262,901 | $31,624,361 | |
| 5 | AMGN |
Amgen Inc
|
54,554 | $19,194,824 | |
| 6 | NVS |
Novartis AG
|
96,473 | $14,736,250 | |
| 7 | PFE |
Pfizer Inc
|
484,920 | $13,616,553 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
220,900 | $13,397,585 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $100,773,812 | 412,264 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $87,586,206 | 423,224 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $70,704,168 | 381,319 | Shares | Sole | 2025-12-02 | |
| 2025-06-30 | $56,926,717 | 372,679 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $54,614,594 | 329,321 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $46,764,757 | 323,363 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $48,116,262 | 296,904 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $42,343,720 | 289,708 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $17,954,406 | 113,499 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $16,349,548 | 104,310 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $16,798,416 | 107,855 | Shares | Sole | 2023-10-31 | |
| 2023-06-30 | $19,030,164 | 114,972 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $16,975,755 | 109,521 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $19,730,921 | 111,695 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $18,014,197 | 110,273 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,231,331 | 80,172 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $10,627,774 | 59,966 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $5,652,666 | 33,043 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $5,322,555 | 32,957 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $5,031,818 | 30,544 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $5,433,411 | 33,060 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $3,478,570 | 22,103 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $3,476,496 | 23,351 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $3,100,610 | 22,048 | Shares | Sole | 2020-07-24 | |
| 2020-03-31 | $3,881,054 | 29,597 | Shares | Sole | 2020-04-17 | |
| No filing history on record for this holder in this stock. | ||||||